• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PROMises Made, PROMises To Be Kept: Patient-Reported Outcome Measures in Inflammatory Bowel Diseases.

作者信息

Singh Siddharth

机构信息

Division of Gastroenterology, University of California San Diego, La Jolla, California; Division of Biomedical Informatics, University of California San Diego, La Jolla, California.

出版信息

Clin Gastroenterol Hepatol. 2018 May;16(5):624-626. doi: 10.1016/j.cgh.2018.01.032. Epub 2018 Jan 31.

DOI:10.1016/j.cgh.2018.01.032
PMID:29409805
Abstract
摘要

相似文献

1
PROMises Made, PROMises To Be Kept: Patient-Reported Outcome Measures in Inflammatory Bowel Diseases.许下的承诺，应予以兑现：炎症性肠病患者报告的结局指标
Clin Gastroenterol Hepatol. 2018 May;16(5):624-626. doi: 10.1016/j.cgh.2018.01.032. Epub 2018 Jan 31.
2
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases.对于炎症性肠病患者日常护理中患者报告的结局而言，黄金时代已然过去。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1839. doi: 10.1016/j.cgh.2018.05.029.
3
Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.炎症性肠病-肠易激综合征在CCFA合作伙伴中对患者报告结局的患病率及影响
Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.
4
Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.实现协同效应：将基于互联网的炎症性肠病队列与基于社区的起始队列以及炎症性肠病多中心队列相联系。
J Med Internet Res. 2016 Jun 3;18(6):e124. doi: 10.2196/jmir.5655.
5
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.炎症性肠病中的患者报告结局指标（PROMs）：新数据
J Crohns Colitis. 2017 Mar 1;11(suppl_2):S576-S585. doi: 10.1093/ecco-jcc/jjw187.
6
Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?炎症性肠病的远程监测：我们应该使用哪种患者报告问卷？
J Crohns Colitis. 2021 May 4;15(5):869-870. doi: 10.1093/ecco-jcc/jjaa228.
7
The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.儿童炎症性肠病中肠易激综合征样症状的流行情况，及其与疾病活动的生化标志物的关系。
Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25.
8
Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).炎症性肠病（IBD）患者的生活质量、功能及胃肠道/精神症状严重程度的患者报告结局
Inflamm Bowel Dis. 2017 May;23(5):798-803. doi: 10.1097/MIB.0000000000001060.
9
Assessment of the Japanese Inflammatory Bowel Disease Questionnaire in patients after ileal pouch anal anastomosis for ulcerative colitis.溃疡性结肠炎患者回肠储袋肛管吻合术后日本炎症性肠病问卷的评估
J Gastroenterol. 2006 Jul;41(7):662-7. doi: 10.1007/s00535-006-1826-x.
10
Potential Pitfalls When Assessing the Impact of Cytomegalovirus in Inflammatory Bowel Disease.评估巨细胞病毒在炎症性肠病中影响时的潜在陷阱。
J Clin Gastroenterol. 2019 May/Jun;53(5):394-395. doi: 10.1097/MCG.0000000000000812.

引用本文的文献

1
Understanding diagnostic delays and health outcomes for inflammatory bowel disease: a mixed-methods study of patients' perspectives.了解炎症性肠病的诊断延迟和健康结局：一项关于患者观点的混合方法研究。
Qual Life Res. 2025 Mar;34(3):823-832. doi: 10.1007/s11136-024-03852-4. Epub 2024 Nov 26.
2
Assessing Severity of Disease in Patients with Ulcerative Colitis.评估溃疡性结肠炎患者的疾病严重程度。
Gastroenterol Clin North Am. 2020 Dec;49(4):671-688. doi: 10.1016/j.gtc.2020.08.003. Epub 2020 Sep 23.
3
UEG framework for the development of high-quality clinical guidelines.
欧洲胃肠病学联盟制定高质量临床指南的框架。
United European Gastroenterol J. 2020 Oct;8(8):851-864. doi: 10.1177/2050640620950854. Epub 2020 Sep 2.
4
Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials.甲氨蝶呤治疗炎症性肠病的疗效与安全性：一项随机对照试验的系统评价与荟萃分析
EClinicalMedicine. 2020 Feb 4;20:100271. doi: 10.1016/j.eclinm.2020.100271. eCollection 2020 Mar.
5
Evolution of Clinical Trials in Inflammatory Bowel Diseases.炎症性肠病临床试验的演变
Curr Gastroenterol Rep. 2018 Aug 4;20(9):41. doi: 10.1007/s11894-018-0648-3.